1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSingle Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Continues support for the EDIC Study Research Center.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) - Federal Grant Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) The summary for the Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants. com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact .
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed): This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information.
In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and only meritorious applications will be considered for funding.
Through this NOFO, the National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites an application to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement that addresses specific knowledge gaps in the development and progression of type 1 diabetes complications.
Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and supporting collaborative research to utilize the EDIC cohort as well as its data set and biologic/genetic samples.
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) National Institutes of Health (HHS-NIH11) Funding Opportunity Number: Current Application Deadline: Original Application Deadline: Maximum Federal Grant Award: Minimum Federal Grant Award: Expected Number of Awards: Cost Sharing or Matching: Applicants Eligible for this Grant Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts.
All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16. 8 Collaborative International Research Awards.
Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding.
This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
Grant Announcement Contact Division of Diabetes, Endocrinology and Metabolic Diseases Similar Government Grants • Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed) • Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney ... • Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury...
• Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) • Silvio O.
Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes • Molecular Therapy Core Centers • Pilot and Feasibility Program in Human Islet Biology More Grants from the National Institutes of Health • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...
• Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not ... • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) • Silvio O.
Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5... Federal Grants by Category Grants for Single Mothers Small Business Grants for Women Federal Grants for College Federal Tuition Assistance
According to the current listing, eligibility includes: Domestic public or private nonprofit institutions of higher education. Confirm the full requirements in the official notice before applying.
Applications for Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) are due November 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NIH Organ-on-Chip Diabetes SBIR: Microphysiological Systems for Diabetes, Kidney, and Urologic Complications Research is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This highlighted topic encourages collaborative research applying human microphysiological systems (MPSs), or organ-on-chip platforms, to cell and tissue types relevant to diabetes and its kidney and urologic complications. High-priority areas include systems with at least two diabetes-relevant human tissues, validation of diabetes pathophysiology, studies of crosstalk between tissues, and models with mature cell types and interacting compartments.
NIDDK Small Business Programs (SBIR/STTR) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK participates in SBIR and STTR programs to support innovative research conducted by small businesses with the potential for commercialization. While their primary focus areas are digestive diseases, nutritional disorders, and obesity, innovations in medical devices that could have an impact on related circulatory or chronic conditions might be considered.
NIDDK Exploratory/Developmental Research Grant Program in Sickle Cell Disease (R21) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This opportunity supports mission-aligned projects and measurable outcomes related to sickle cell disease research. The R21 mechanism encourages the development of new research activities in categorical program areas.